{"id": 6969, "input_str": " CHESTERBROOK, Pa., Dec. 1, 2014 /PRNewswire/ -- Animas Corporation today announced FDA approval of the Animas\u00ae Vibe\u2122 insulin pump and Continuous Glucose Monitoring (CGM) system for the management of insulin-requiring", "correct_token_str": " diabetes", "generated_token_str": ",", "generator_index": 2, "correct_logprobs": [-6.5495758056640625, -1.2321574687957764, -1.0772682428359985], "generated_logprobs": [-3.7563397884368896, -5.1799726486206055, -5.292867183685303], "generator_names": ["gelu_two_layers/", "gelu_twelve_layers/", "gelu_twenty_four_layers/"]}